Morgan Stanley Call 160 iShares Nasdaq Biotechnology ETF 20.09.2024
/ DE000ME17GN6
Morgan Stanley Call 160 iShares N.../ DE000ME17GN6 /
| 10/07/2024 20:44:41 |
Chg.+0.003 |
Bid22:00:34 |
Ask22:00:34 |
Underlying |
Strike price |
Expiration date |
Option type |
| 0.063EUR |
+5.00% |
-
Bid Size: - |
-
Ask Size: - |
- |
160.00 - |
20/09/2024 |
Call |
Master data
| WKN: |
ME17GN |
| Issuer: |
Morgan Stanley |
| Currency: |
EUR |
| Underlying: |
- |
| Type: |
Warrant |
| Option type: |
Call |
| Strike price: |
160.00 - |
| Maturity: |
20/09/2024 |
| Issue date: |
27/09/2023 |
| Last trading day: |
20/09/2024 |
| Ratio: |
10:1 |
| Exercise type: |
American |
| Quanto: |
No |
| Gearing: |
168.95 |
| Leverage: |
Yes |
Calculated values
| Fair value: |
0.00 |
| Intrinsic value: |
0.00 |
| Implied volatility: |
0.34 |
| Historic volatility: |
0.15 |
| Parity: |
-3.16 |
| Time value: |
0.08 |
| Break-even: |
160.76 |
| Moneyness: |
0.80 |
| Premium: |
0.25 |
| Premium p.a.: |
2.12 |
| Spread abs.: |
0.02 |
| Spread %: |
24.59% |
| Delta: |
0.09 |
| Theta: |
-0.02 |
| Omega: |
15.23 |
| Rho: |
0.02 |
Quote data
| Open: |
0.062 |
| High: |
0.063 |
| Low: |
0.062 |
| Previous Close: |
0.060 |
| Turnover: |
0.000 |
| Market phase: |
- |
All quotes in EUR
Performance
| 1 Week |
|
|
+152.00% |
| 1 Month |
|
|
+57.50% |
| 3 Months |
|
|
+28.57% |
| YTD |
|
|
-70.00% |
| 1 Year |
|
|
- |
| 3 Years |
|
|
- |
| 5 Years |
|
|
- |
| 10 Years |
|
|
- |
| 1W High / 1W Low: |
0.060 |
0.025 |
| 1M High / 1M Low: |
0.060 |
0.025 |
| 6M High / 6M Low: |
0.230 |
0.019 |
| High (YTD): |
09/01/2024 |
0.270 |
| Low (YTD): |
26/04/2024 |
0.019 |
| 52W High: |
- |
- |
| 52W Low: |
- |
- |
| Avg. price 1W: |
|
0.049 |
| Avg. volume 1W: |
|
0.000 |
| Avg. price 1M: |
|
0.045 |
| Avg. volume 1M: |
|
0.000 |
| Avg. price 6M: |
|
0.100 |
| Avg. volume 6M: |
|
0.000 |
| Avg. price 1Y: |
|
- |
| Avg. volume 1Y: |
|
- |
| Volatility 1M: |
|
452.83% |
| Volatility 6M: |
|
264.30% |
| Volatility 1Y: |
|
- |
| Volatility 3Y: |
|
- |
